• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4介导的T细胞反应调节中的抑制作用:肿瘤免疫治疗中的机制与调控

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

作者信息

Chambers C A, Kuhns M S, Egen J G, Allison J P

机构信息

University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

出版信息

Annu Rev Immunol. 2001;19:565-94. doi: 10.1146/annurev.immunol.19.1.565.

DOI:10.1146/annurev.immunol.19.1.565
PMID:11244047
Abstract

The T cell compartment of adaptive immunity provides vertebrates with the potential to survey for and respond specifically to an incredible diversity of antigens. The T cell repertoire must be carefully regulated to prevent unwanted responses to self. In the periphery, one important level of regulation is the action of costimulatory signals in concert with T cell antigen-receptor (TCR) signals to promote full T cell activation. The past few years have revealed that costimulation is quite complex, involving an integration of activating signals and inhibitory signals from CD28 and CTLA-4 molecules, respectively, with TCR signals to determine the outcome of a T cell's encounter with antigen. Newly emerging data suggest that inhibitory signals mediated by CTLA-4 not only can determine whether T cells become activated, but also can play a role in regulating the clonal representation in a polyclonal response. This review primarily focuses on the cellular and molecular mechanisms of regulation by CTLA-4 and its manipulation as a strategy for tumor immunotherapy.

摘要

适应性免疫中的T细胞区室使脊椎动物有潜力去探测并特异性地应对种类繁多的抗原。T细胞库必须得到精心调控,以防止对自身产生不必要的反应。在外周,一个重要的调控层面是共刺激信号与T细胞抗原受体(TCR)信号协同作用,以促进T细胞的完全活化。过去几年的研究表明,共刺激相当复杂,分别涉及来自CD28和CTLA-4分子的激活信号和抑制信号与TCR信号的整合,以决定T细胞与抗原相遇的结果。新出现的数据表明,CTLA-4介导的抑制信号不仅能决定T细胞是否被激活,还能在多克隆反应中调节克隆代表性方面发挥作用。本综述主要关注CTLA-4的调控细胞和分子机制及其作为肿瘤免疫治疗策略的操控。

相似文献

1
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.CTLA-4介导的T细胞反应调节中的抑制作用:肿瘤免疫治疗中的机制与调控
Annu Rev Immunol. 2001;19:565-94. doi: 10.1146/annurev.immunol.19.1.565.
2
CTLA-4: new insights into its biological function and use in tumor immunotherapy.细胞毒性T淋巴细胞相关抗原4:对其生物学功能及在肿瘤免疫治疗中应用的新见解
Nat Immunol. 2002 Jul;3(7):611-8. doi: 10.1038/ni0702-611.
3
Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因敲除小鼠的淋巴增殖性疾病的特征是Th2反应由CD28调节激活。
J Immunol. 1999 May 15;162(10):5784-91.
4
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.CD28/B7:CTLA-4共刺激通路在自身免疫和移植中的复杂性
Annu Rev Immunol. 2001;19:225-52. doi: 10.1146/annurev.immunol.19.1.225.
5
Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.体内微量抗原特异性CD4+ T细胞群体的抗原依赖性克隆扩增依赖于CD28共刺激,并受到CTLA-4的抑制。
J Immunol. 1995 Aug 1;155(3):1032-6.
6
Expression and functional significance of CTLA-4, a negative regulator of T cell activation.T细胞活化负调节因子CTLA-4的表达及功能意义
Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46.
7
Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.CTLA-4在调节静息记忆性与初始CD4 T细胞活化中的不同作用。
J Immunol. 1998 Dec 1;161(11):5855-61.
8
Costimulation and its role in organ transplantation.共刺激及其在器官移植中的作用。
Clin Transplant. 1996 Feb;10(1 Pt 2):104-9.
9
Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.通过CD28和CTLA-4发出的信号控制着两种不同形式的T细胞无能。
J Clin Invest. 2001 Sep;108(6):895-903. doi: 10.1172/JCI13220.
10
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.细胞毒性T淋巴细胞相关抗原4(CTLA-4)在外周T细胞耐受性诱导及维持中的作用。
Eur J Immunol. 2002 Apr;32(4):972-81. doi: 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M.

引用本文的文献

1
Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.癌症治疗中HSP90抑制剂的联合策略:作用机制、挑战与未来展望
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1083. doi: 10.3390/ph18081083.
2
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management.微生物群失调与免疫检查点抑制剂:肝细胞癌治疗中的双重靶点
World J Hepatol. 2025 Jul 27;17(7):106810. doi: 10.4254/wjh.v17.i7.106810.
3
TNFAIP8L3 regulation of the TGF-β signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer.
TNFAIP8L3对转化生长因子-β信号通路的调控在肿瘤抗原呈递过程中影响巨噬细胞比例,并影响卵巢癌的预后。
Front Mol Biosci. 2025 Apr 24;12:1566363. doi: 10.3389/fmolb.2025.1566363. eCollection 2025.
4
Cancer chemoprevention: signaling pathways and strategic approaches.癌症化学预防:信号通路与策略方法
Signal Transduct Target Ther. 2025 Apr 18;10(1):113. doi: 10.1038/s41392-025-02167-1.
5
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy.用于癌症免疫治疗中mRNA递送的脂质纳米颗粒
AAPS J. 2025 Mar 18;27(3):66. doi: 10.1208/s12248-025-01051-8.
6
NPC1L1 on pancreatic adenocarcinoma cell functions as a two-pronged checkpoint against antitumor activity.胰腺腺癌细胞上的NPC1L1作为对抗肿瘤活性的双叉检查点发挥作用。
Innovation (Camb). 2025 Jan 21;6(3):100783. doi: 10.1016/j.xinn.2024.100783. eCollection 2025 Mar 3.
7
Research hotspots and trends of immunotherapy and melanoma: A bibliometric analysis during 2014-2024.免疫疗法与黑色素瘤的研究热点及趋势:2014 - 2024年文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2464379. doi: 10.1080/21645515.2025.2464379. Epub 2025 Feb 26.
8
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.靶向PD-1/PD-L1信号通路用于癌症治疗:聚焦生物标志物。
Int J Mol Sci. 2025 Jan 31;26(3):1235. doi: 10.3390/ijms26031235.
9
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment.癌症治疗中使免疫检查点抑制剂致敏的当前趋势。
Mol Cancer. 2024 Dec 26;23(1):279. doi: 10.1186/s12943-024-02179-5.
10
Into the Future: Fighting Melanoma with Immunity.展望未来:借助免疫疗法对抗黑色素瘤。
Cancers (Basel). 2024 Nov 29;16(23):4002. doi: 10.3390/cancers16234002.